ATAI

formerly Atai Life SciencesIPO

AtaiBeckley | Creating breakthroughs in mental health

Public · Berlin, Germany · Founded 2018 · $422.4M raised

Headquarters
Berlin
Employees
51–200
Founded
2018
Business Model
B2B
Website
atai.life
Total Funding
$422.4M
Last Round
$50.0M Private EquityJul 2025
Rounds
7
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

AtaiBeckley Inc. is a clinical-stage biopharmaceutical company formed in 2025 through the strategic combination of atai Life Sciences, founded in 2018, and Beckley Psytech, focused on developing rapid-acting, durable and convenient treatments for difficult-to-treat mental health conditions such as treatment-resistant depression. In July 2026, Eli Lilly agreed to acquire the company for approximately $6.75 per share in cash, an equity value of about $2.8 billion, pending closing.

Summary

ATAI is a Biotech company based in Berlin, Germany, founded in 2018. It has raised $422.4M in total across 7 rounds, most recently a $50.0M Private Equity round in Jul 2025. Investors include Apeiron Investment Gro, Catalio Capital Management and Peter Thiel.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Private EquityPrivate EquityJul 2025
$50.0M

Sign up to see all 8 events

Funding: Seed through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

COMPASS PathwaysIPO

COMPASS Pathways is dedicated to accelerating patient access to evidence-based innovation in ment...

London, United Kingdom51–200Healthcare, Mental Health
Venture RoundTotal funding$997.0MFeb 2026
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ATAI on Indexed.vc
<a href="https://indexed.vc/companies/atai"><img src="https://indexed.vc/api/badge/company/atai" alt="ATAI on Indexed.vc" width="260" height="76" /></a>